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Abstract
Case presentation: A 46-year-old man suffering from pro-
gressive deafness since childhood received a Clarion 90 K
cochlear implant with the HiRes preformed electrode in his
left ear in October 2006. A persistent Staphylococcus aureus
infection failed to be treated with corticoids, amoxicillin/
clavulanate, ciprofloxaxin, and rifampin. The processor was
removed on July 2007.
Interventions: The removed cochlear implant processor was
treated with different reagents, with the aim of detecting a
S. aureus and S. aureus biofilm: (1) fluorescein-coupled Fc of
anti-human serum, (2) polyclonal anti-polysaccharide
intercellular adhesion antibodies coupled to Alexa Fluor 568
goat anti-rabbit immunoglobulin (Ig)G, (3) crystal violet,
(4) methylene blue, (5) acridine orange, (6) Gram stain, and
(7) live/dead fluorescent stain.
Results: S. aureus and the major constituent of the
S. aureus biofilm, the polysaccharide intercellular adhesion,
were detected on the surface of the implant. S. aureus was
isolated after a simple contact between the implant and a
solid growth medium. The ability of the isolated S. aureus
strain to produce biofilm in vitro was confirmed.
Interpretation: S. aureus biofilm was documented on the
implant. Initial bacterial colonization could be related to
the pocket of the removable magnet. Colonies of S. aureus
without biofilm were found attached to the electrode wire.
Conclusion: We report one case of a S. aureus biofilm
infection documented on a cochlear implant, as assessed
by immuno-microscopy. The biofilm was likely responsible
for the persistent infection which manifested for many
months after the implant surgery and could explain the
unusual bacterial phenotypic resistance against adminis-
tered antimicrobial agents.
Infection 2009; 37: 450–454
DOI 10.1007/s15010-008-8335-1
Introduction
Until recently, medical complications associated with co-
chlear implants were mainly related to flap necrosis,
incision dehiscence, and post-operative wound infections
[4, 11, 23]. The incidence of such complications was low,
and they were usually successfully managed with antibi-
otics and/or plastic and middle ear surgery. Cases of
persistent infection requiring the removal of the processor
have been rare, and some have even been attributed to a
primary immunodeficiency of the recipient [23]. Similarly
to what has been observed on other types of implants [5],
reports of biofilm formation on the surface of cochlear
implants started to appear in print in 2004 [1, 17, 20].
Clinically, biofilms are complex bacterial communities
that adhere to the surface of implanted biomaterial or
mucosa [9, 18] and produce an extra-cellular matrix [3],
leading to increased bacterial resistance against the host’s
immune defenses and to antibiotics [22]. Since 1985, 200
patients have been implanted at the Geneva Cochlear
Implant Centre. Different types of implants have been
used and, until recently, not a single case of wound
dehiscence, flap necrosis, or infection of the processor has
been observed. In 2007, we were confronted with an
atypical and persistent infectious case that required re-
moval of the processor, a Clarion 90 K cochlear implant
with the HiRes preformed electrode, which was then
submitted to microbiological analysis.
Case History
In October 2005, a 46-year-old man suffering from progressive
deafness since childhood received a Clarion 90 K cochlear
implant with the HiRes preformed electrode in his left ear.
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Surgery was performed according to the minimally invasive
technique described byO’Donoghue and Nikolopoulos [19]. The
processor was placed in a muscle pouch and attached to the
bone. The patient was given intravenous ceftriaxone during the
surgery, followed by amoxicillin/clavulanate (orally) for 1 week
post-surgery. Healing was uneventful. Two months after cochlear
implantation the patient had achieved a very good performance
and was wearing his implant daily. 17 months after the surgery,
however, he felt an increasing retro-auricular pain, and the site
of the processor became swollen. We suspected that a hematoma
had developed inside the muscle pouch containing the processor
and treated the symptoms with corticoids and amoxicillin/cla-
vulanate orally. The swelling and pain disappeared in 15 days,
but reappeared 6 weeks later. Puncture removed 3 cc of a citrin
liquid, and subsequent culture of the liquid showed the growth of
Staphylococcus aureus sensitive to all tested antibiotics with the
exception of penicillin G. The patient received a treatment of
ciprofloxacin and rifampin for 8 weeks, but the swelling, redness,
and pain persisted. Surgical drainage was performed. The sur-
rounding tissue was debrided, and the muscle pouch and the
processor were irrigated with antibiotics. Culture showed again
S. aureus. The wound healed, but 2 weeks later liquid had again
collected. The processor was removed in July 2007. The elec-
trode wire was sectioned at the level of the cochleostomy, and
the electrode array was left inside the cochlea. The wound healed
in 2 days. Three months later the patient received a new cochlear
implant, which was switched on 2 weeks after surgery. The pa-
tient has since reached the same performance levels with the new
implant as he had with the original one.
Material and Methods
Microbiological Sampling, Cultures, and
Identification of the Strain of S. aureus
During the removal surgery, samples were collected from the
inguinal, axillary, retro-auricular, and external ear canal skin,
from nasal and throat mucosa, and from fragments of the sur-
rounding tissue. The identification of a strain of S. aureus was
performed according to Clinical and Laboratory Standards
Institute (CLSI) recommendations and included Pastorex
agglutination (Bio-Rad, Hercules, CA) and the DNAse pro-
duction test. A real time-PCR amplification procedure [8] was
performed for confirmation.
S. aureus growth was achieved by culturing the removed
processor on Mueller Hinton agar (MHA; Bio-Rad, Marnes-La-
Coquette, France). S. aureus strain SA113 (ATCC 35556) and its
ica mutant (Dica::tet) were used as control for immuno-detection
of polysaccharide intercellular adhesion (PIA) [10]. MHA and
trypticase soy broth (TSB; Becton Dickinson, Le Pont de Claix,
France) supplemented with 1% glucose (TSBgluc) were used for
bacterial growth. The in vitro formation of the biofilm was tested
on a strain grown in TSBgluc medium during a 15-h culture. A
glass coverslip was added to the well prior to culture for the
detection of PIA.
Pre-Treatment of the Processor
The processor body was divided into two parts. The silicon part
harboring the removable magnet pocket after the magnet was
removed was snap-frozen in liquid nitrogen and conserved at
80 C. Before testing, the device was washed with a PBS solution
(Invitrogen, Carlsbad, CA) and sliced into five pieces, which
were deposited in separated wells on a six-well plate. The other
part, which included the electrode wire, was washed with PBS,
immediately fixed for 1 h in 2% v/v glutaraldehyde (Fluka,
Chemica, Germany) in PBS, and conserved in a PBS solution at
4 C. Before testing, this part and the electrode wire were sliced
into five pieces each.
Crystal Violet Staining Assay for Initial Evaluation
of the Presence of the Biofilm
Glutaraldehyde-fixed implant sections and thein vitro heat-fixed
bacteria biofilm were stained for 10 min with 1% (w/v) crystal
violet (CV) stain freshly diluted twofold in 1% ethanol/distilled
water, as previously described [21]. The stained material was
then washed three times with PBS and inspected with the naked
eye and by white light microscopy.
Immuno-Detection of PIA
Sections of the processor and in vitro biofilm from the S. aureus
grown on a circular glass coverslip (diameter 25 mm) were wa-
shed twice with PBSAT (PBS containing 0.02% azide and 0.05%
Tween. 20) with slow shaking for 5 min. Cross-reactions with S.
aureus protein A were blocked by incubating the material for 2 h
with 1:1,000 normal donkey serum (Jackson Immuno Research,
West Grove, PA). For specific detection of PIA, the material was
incubated for 1 h with 1:3,000 a-PIA rabbit polyclonal anti-PIA
antibody [15], then washed twice with PBSAT. The binding of
specific antibodies was revealed after incubation with 1:3,000
dilution of Alexa Fluor 568 goat anti-rabbit IgG (H + L)
(Molecular Probes, Eugene, OR) as secondary antibody. The
material was washed with a PBS solution (PBSAT) containing
1% albumin (ZLB Behring AG, Bern, Switzerland) and 0.1%
tween-20 (Fluka).
Immuno-detection of S. aureus Through Binding
to Cell-Wall Protein A
Processor sections and the slices of the electrode wire were
incubated for 30 min with PBSAT and for 30 min with 1:1,000
fluorescein-coupled to the Fc fragment of goat anti-human serum
(Jackson Immuno Research). The slices were then washed five
times with PBSAT before being observed under the microscope.
Immuno-Fluorescent Microscopy
All incubations were performed in PBSAT. A humid chamber
was prepared for antibody incubations, consisting of a six-well
plate that was hermetically sealed with Parafilm and light-pro-
tected with aluminium foil. Images were acquired by an Axiocam
color camera (Zeiss, Iena, Germany) on an Axioskop 2 micro-
scope (Zeiss). Ultraviolet excitation for fluorescent imaging and
white light microscopy were performed both separately and in
combination. Filter set 09 (Zeiss; excitation BP 450–490, emission
LP 515) was used for PIA immuno-detection through Alexa Fluor
detection (emission 603 nm), whereas Filter set 02 (Zeiss; exci-
tation G 365, emission LP 420) was used to detect fluorescein
isothiocyanate (FITC; emission 530 mm ± 15 nm), indicating the
presence of S. aureus through the binding of the Fc fragments to
bacterial protein A. Scaling was performed automatically with the
AxioVision software (Zeiss) according to the objective in use.
Results
Bacterial Recording
Staphylococcus aureus was identified in the external ear
canal and retro-auricular swabs, in the tissue fragments,
and in the liquid surrounding the implant collected dur-
ing the removal surgery. Identification was performed
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according to CLSI recommendations. Identification of the
bacterium was based on a positive by Pastorex agglutina-
tion and DNAse production tests. Confirmation was ob-
tained using a previously described duplex PCR
amplification. S. aureus was also detected by the direct
growth of the bacterium following culture of the explanted
implant on a solid medium in a petri dish, yielding a pure
culture. The isolated S. aureus strain was named ‘‘Coch’’.
S. aureus Biofilm Identification on the Cochlear
Implant
The biofilm was detected on the glutaraldehyde-fixed part
of the implant containing the magnet pocket (Figure 1a).
Cochlear implant pieces were successfully stained with
CV in different zones visible to the naked eye. These
colored zones were less abundant than areas reacting with
the methylene blue stain. White-light microscopic obser-
vations of CV-stained zones showed an association
with cocci (Ø = 1 lm) (Figure 1b). Presence of adherent
S. aureus on the implant was confirmed by the immuno-
detection of protein A using a FITC-coupled immuno-
globulin (Figure 1c). The presence of the biofilm was
postulated in these CV-stained zones and confirmed
using specific antibodies raised against S. aureus PIA
(Figure 1d). Surface PIA-positive zones were less abun-
dant than CV-stained zones.
In vitro PIA-based Biofilm Formation
Coch strain produced PIA in vitro on glass coverslips at
amounts quite similar to those of the control laboratory
strain SA113 (Figure 2). Surface colonization to be ap-
peared homogeneous for strain SA113 in vitro, whereas
strain Coch showed punctual aggregates. The ica mutant
was negative for PIA-specific fluorescence (Figures 1, 2).
Binding of Fluorescent Fc Fragments
on the Electrode Wire
Immuno-detection performed on the electrode wire was
positive for S. aureus on the first five proximal sections
(corresponding to a 4.4-cm length from the implant side)
as revealed by Fc-FITC binding (not shown). The three
most distal fragments studied were negative.
Figure 1. Microscopy imaging of
the removed cochlear implant. a)
Magnet pocket of the explanted
Clarion 90 K cochlear implant. The
successfully stained zones depicted
on panels b, c, d are localized near
the recess surrounding the magnet
(A ¼ 8 mm, see arrow). b) Crystal
violet-stained zone associated with
cocci-like structures. c) Immuno-
fluorescence microscopy showing
the presence of S. aureus protein A.
d) Immuno-fluorescence
microscopy showing the presence
of biofilm-associated
polysaccharide intercellular
adhesion (PIA). Scale bars: 20 lm.
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Discussion
Worldwide, only two cases of implant extrusion due to
persistent infections by S. aureus have been clearly asso-
ciated to biofilms. In these cases, identification was per-
formed using scanning electron microscopy [1, 20]. We
report here a third case of S. aureus biofilm infection of a
Clarion HiRes 90 K cochlear implant. The microscopic
appearance of the biofilm-related PIA matrix produced by
the isolated S. aureus strain, denoted here as Coch, dif-
fered between the in vitro and ex vivo experiments. CV
staining is an easy indirect procedure that can be used to
quantify biofilm in vitro [7, 21], but it has never been used
for ex vivo biofilm detection. Our case is therefore the first
time this procedure has been applied to detect bacterial
biofilm on ex vivo materials as an initial evaluation of the
surface of the implant. Cocci-like structures (A approx. 1
lm) were clearly visible in the microscopic observations.
Taken together, PIA immuno-detection and CV staining
confirmed the presence of a S. aureus biofilm on the sur-
face of the implant inside the pocket of the removable
magnet. Analysis of the magnet itself was impossible for
technical reasons. We speculate that S. aureus contami-
nated first a hematoma inside the muscle pouch made to
hold the processor and subsequently the processor itself.
Even though a treatment of amoxicillin/clavulanate fol-
lowed by ciprofloxacin and rifampin was given as soon as a
biofilm infection was suspected, the processor had to be
ultimately explanted. This case illustrates how efficiently
the bacterial community resisted the host immune re-
sponse and the antibiotics that are effective when the
same bacteria are in their planktonic form [3] and con-
firms that biofilm contamination of an implant often
requires removal of the latter [5]. S. aureus had already
been detected on the culture of the puncture carried out at
the early stage of the disorder. There have been published
cases of redness and tenderness around the processor
followed by flap necrosis or dehiscence and, ultimately,
rejection of the processor. These cases were suspected to
be caused by an allergy to one of the implant components
[16] because no germs could be detected. However, even
in such cases, biofilm infections should not be excluded.
Sub-clinical biofilm infections can persist for many years
before they manifest [11]; therefore, a biofilm infection
cannot be ruled out based on a negative culture of the
material [14].
Antibiotic prophylaxis is recommended for surgeries
involving implants, but the postoperative use of antibiot-
ics is not [2]. This latter practice has, since this case, been
abandoned by our center. Although we consider the case
reported here to be unique among all the procedures
carried out at our center, representing 0.5% of our im-
plants, the post-operative use of antibiotics could have
contributed to increasing the resistance of the infecting
bacteria and the formation of biofilm.
The first processors implanted in the 1980s were
sealed in a smooth ceramic case [13]. The contribution of
bacterial biofilm-related infection to the frequency of
implant removal is clearly under-reported in the literature
as biofilm presence has not been not systematically as-
sessed. In 2000, new processors constructed out of flexible
silastic and containing a removable magnet pocket were
developed by Cochlear and by Advanced Bionics. Two
recent studies in which this type of implant was used have
reported the presence of biofilm scattered over the entire
the surface of the devices [1, 20]. The authors of another
report observed a higher abundance of biofilm and bio-
film-associated bacteria inside the depressions on the
body processor [17]. In the latter study, Loeffler et al. [17]
Figure 2. In vitro production of PIA.
Microscopic pictures of in vitro
biofilms formed on glass coverslips
of Coch (left column), SA113 (middle
column), and SA113Dica (right
column). Row A: Adherent bacteria
visible using white light
microscopy. Row B: Pictures of PIA
immuno-detection on the
corresponding surfaces. Scale bars:
20 lm.
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also reported higher counts of bacteria on implants har-
boring an empty magnet pocket as compared to models
without a magnet pocket.
As reported previously by other authors [1, 17, 20], we
cannot confirm the presence of biofilm around the elec-
trode wire. The tests performed after the removal of the
processor revealed that there was S. aureus attached to
the electrode wire up 4.4 cm distally from the body of the
processor, but these are not specific for the detection of
biofilm. In our case, during the removal surgery, the length
of the wire that extended from the mastoid to the cochl-
eostomy appeared to be normal. We arbitrarily decided to
cut the wire at the level of the cochleostomy and leave the
electrodes array inside the cochlea to avoid obliteration by
fibrous tissue that could prevent a new implant.
Modern processors equipped with a removable mag-
net represent a major improvement for patients suffering
from chronic disease that requires regular follow-up with
MRIs. The ability to remove the magnet removes the risk
of magnet mobilization or demagnetization in patients
requiring radiological examination. Unfortunately the
pocket designed to encase the magnet seems to favor
biofilm formation, and the possibility that this pocket is
involved in biofilm formation should not be ignored.
Technical developments are under way to avoid the for-
mation of bacterial biofilms, such as surface treatment with
antimicrobial molecules [6]. Clearly, such developments
need careful evaluation in the clinical context [6, 12].
In conclusion, biofilm can cause resistant infections of
cochlear implants that manifest many months after the
surgery. The pocket of the removable magnet could be
one niche facilitating biofilm, formation although coloni-
zation of the electrode wire is not excluded.
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